2023-08-01 2024-07-31 false No description of principal activity Acting Office - Tax and Accounts 1.0 12087522 bus:FullAccounts 2023-08-01 2024-07-31 12087522 bus:Micro-entities 2023-08-01 2024-07-31 12087522 bus:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 12087522 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 12087522 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 12087522 2023-08-01 2024-07-31 12087522 2024-07-31 12087522 bus:RegisteredOffice 2023-08-01 2024-07-31 12087522 core:WithinOneYear 2024-07-31 12087522 core:AfterOneYear 2024-07-31 12087522 2022-08-01 12087522 bus:Director1 2023-08-01 2024-07-31 12087522 bus:Director1 2024-07-31 12087522 bus:Director1 2022-08-01 2023-07-31 12087522 bus:CompanySecretary1 2023-08-01 2024-07-31 12087522 bus:LeadAgentIfApplicable 2023-08-01 2024-07-31 12087522 2022-08-01 2023-07-31 12087522 2023-07-31 12087522 core:WithinOneYear 2023-07-31 12087522 core:AfterOneYear 2023-07-31 12087522 bus:EntityAccountantsOrAuditors 2022-08-01 2023-07-31 12087522 core:ComputerEquipment 2023-08-01 2024-07-31 12087522 core:ComputerEquipment 2024-07-31 12087522 core:ComputerEquipment 2023-07-31 12087522 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-07-31 12087522 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-07-31 12087522 core:CostValuation core:Non-currentFinancialInstruments 2024-07-31 12087522 core:CostValuation core:Non-currentFinancialInstruments 2023-07-31 12087522 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-07-31 12087522 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-07-31 12087522 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-07-31 12087522 core:Non-currentFinancialInstruments 2024-07-31 12087522 core:Non-currentFinancialInstruments 2023-07-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12087522
England and Wales

 

 

 


Unaudited Financial Statements

for the year ended 31 July 2024

for

BIOFUSE CONSULTING LIMITED

 
 
 
£
2024
£
   
£
2023
£
Fixed assets 3,130  1,731 
Current assets 321,151  334,454 
Creditors: amount falling due within one year (54,041) (36,590)
Net current assets/(liabilities) 267,110  297,864 
Total assets less current liabilities 270,240  299,595 
Accrued liabilities (328) (294)
Net assets/(liabilities) 269,912  299,301 
 
Capital and reserves 269,912  299,301 
 
  1. For the year ended 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:


----------------------------------
Stuart John Whiting
Director

Date approved: 25 April 2025
1
Statutory Information
BIOFUSE CONSULTING LIMITED is a private limited company, limited by shares, domiciled in England and Wales, registration number 12087522, registered office Optionis House 840 Ibis Court, Centre Park, Warrington, WA1 1RL, England.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the year was 1 (2023: 1).
2